Provided by Tiger Trade Technology Pte. Ltd.

ResMed

225.98
+5.292.40%
Volume:1.13M
Turnover:255.41M
Market Cap:31.86B
PE:21.67
High:228.75
Open:222.27
Low:221.83
Close:220.69
52wk High:284.87
52wk Low:180.27
Shares:141.00M
Float Shares:140.00M
Volume Ratio:1.11
T/O Rate:0.81%
Dividend:2.40
Dividend Rate:1.06%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:4.84
PE(LYR):21.67

Loading ...

ResMed Earnings Growth Seen Strong as Ventilator Issue Clouds FY27, UBS Says

MT Newswires Live
·
Jul 22

Resmed Bulls Think Acquisition Timing Looks Awkward

Dow Jones
·
Jul 21

RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276

MT Newswires Live
·
Jul 17

ResMed downgraded to Sector Perform from Outperform at RBC Capital

TIPRANKS
·
Jul 16

ResMed price target lowered to $220 from $235 at Mizuho

TIPRANKS
·
Jul 15

RMD or the 4% Rule? One Lets You Live Large and not Run Out of Money.

Dow Jones
·
Jul 15

Baird Adjusts ResMed Price Target to $217 From $225, Maintains Neutral Rating

MT Newswires Live
·
Jul 14

Cleveland Medical Devices: Won Favorable Ptab Outcomes in 5 of 6 Resmed Ipr Challenges

THOMSON REUTERS
·
Jul 14

Cleveland Medical Devices: in Four of Five Proceedings, Ptab Determined That Co Had not Established That Challenged Claims were Unpatentable

THOMSON REUTERS
·
Jul 14

Movement Alert|ResMed Falls 5.61% in Regular Trading, Citi Downgrades Rating to Neutral Triggering Sell-Off

Market Focus
·
Jul 13

Movement Alert|ResMed Falls 5.19% in Pre-Market Trading, Citi Downgrades Rating to Neutral

Market Focus
·
Jul 13

RMD or the 4% Rule? One Lets You Live Large and not Run Out of Money.

Dow Jones
·
Jul 13

Resmed Cut to Neutral from Buy by Citigroup

Dow Jones
·
Jul 13

3 US Healthcare Stocks Investors May Revisit As Inflation Pressures Build

Simply Wall St.
·
Jul 13

Citi Downgrades ResMed to Neutral From Buy; Price Target is AU$34

MT Newswires Live
·
Jul 13

ResMed downgraded to Neutral from Buy at Citi

TIPRANKS
·
Jul 13

Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Eli Lilly & Co (LLY)

TIPRANKS
·
Jul 13

RMD or the 4% Rule? One Lets You Live Large and not Run Out of Money.

Dow Jones
·
Jul 11

Resmed is Maintained at Hold by Jefferies

Dow Jones
·
Jul 11

ResMed price target lowered to $225 from $240 at Jefferies

TIPRANKS
·
Jul 10